Skip to content
AXLRx

Consulting-grade commercial intelligence, in days not months.

AXLRx is a custom-built commercial consulting engine for pharma: targeted, evidence-led answers to the commercial questions that move decisions, across any therapeutic area, geography, and stage of the lifecycle. Grounded in 50+ live data sources and 20 years of pharma commercial practice.

 First brief is free — a $2,000 value. No commitment.

The Evidence Backbone
20+ years of pharma practice
Real commercial judgment, not generic analysis
100+ engagements delivered
Across launches, strategy, and operations
50+ live data sources
PubMed, ClinicalTrials.gov, FDA, EMA, AdisInsight, WHO
Every figure traceable
Sourced, verified, and ready to defend
Not a generic AI tool — no hallucinated sources, no generic answers, no inconsistent output. Purpose-built for pharma commercial questions.
From competitive landscapes to access strategy and launch planning, AXLRx adapts to the question in front of you.
MoatRx Consulting

Pharma commercial strategy that executes, not just advises.

We partner with pharmaceutical and biotech commercial teams to close the Execution Gap: the distance between a sound strategy and results that compound. Our work is embedded, evidence-led, and built to leave capabilities behind.

20+
Years pharma
commercial experience
100+
Engagements delivered
across 4 regions
50+
Live data sources
powering AXLRx
GCC
Specialist depth in
Gulf and MENA markets
Research Reports

311 commercial intelligence reports, already written.

Browse research reports →

Published by AXLRx across 20 indications in Immunology, Metabolic, Neurology, Oncology and Rare Disease — competitive intelligence, disease landscape, market sizing, patient flow, pricing, payer and HTA. Search the full library on axlrx.ai.

See what is live →

Ready to close the Execution Gap?

Let's talk about your commercial challenge. No obligation, no pitch deck.